Mechanism of action biomarkers predicting response to AKT inhibition in the I-SPY 2 breast cancer trialDenise M. Wolf, Laura van ‘t Veer, Rosa I. Gallagher et al.|npj Breast Cancer|2020Cited by 35
Abstract PD9-04: Identification of biomarkers associated with therapeutic resistance: Quantitative protein/phosphoprotein analysis of ~750 patients across 8 arms of the neoadjuvant I-SPY 2 TRIAL for high-risk early stage breast cancerJulia Wulfkuhle, Emanual Petricoin, Denise Wolf et al.|Cancer Research|2021Cited by 0